Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
RVXCF
Primary Symbol:
T.RVX
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on Aug 31, 2022 4:58pm
criminals get compensation
you have GOT to be KIDDING ME! havent checked ca insider for a while, for this reason! 400k RSU's given to the chief liar himself. thats criminal with what he's done. NOTHING! I
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 30, 2022 7:36am
RE:RE:RE:Sarah gone, dr wong gone
Good morning GV,,,,,,,,I would think HL will politic one or more of the other insiders to carry a vote in what ever direction suits them. Of course with the routine kickbacks in place. DMcC has no
...more
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(116)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Aug 29, 2022 10:52am
RE:RE:Sarah gone, dr wong gone
narmac, " Hepalink cleaning out some insiders setting up for their major move I assume." As long as they're willing to pay a fair price for the 64 % of RVX stock they don't own. And
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 28, 2022 7:30pm
RE:Sarah gone, dr wong gone
,,Hepalink cleaning out some insiders setting up for their major move I assume. The Chinese will outsmart our CEO!,,Watch and see!,,Its not the first day in the Market for these guys or ourselves
...more
(12)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on Aug 27, 2022 9:56am
Sarah gone, dr wong gone
Who's next? Sarah's linked in profile says experience for both zenith June 2013 - July 2022, and Resverlogix may 2005 - July 2022. Both companies list end date of July 2022. Looks like
...more
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 24, 2022 8:42pm
RE:Type C Meeting
,,see ,,the senior excects at RVX are possibly on apabetalone,,,,however,,,since these people dont understand the MOA of apabetalone they very likely are experiencing the opposite outcome than
...more
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Post by
Jesus4Prez
on Aug 24, 2022 2:37pm
Type C Meeting
Hi G, I stopped short of saying it has happened because the message from Chris said it wasn't cancelled. That of course leaves room for a postponement, but I doubt it. It sounds like
...more
(17)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Aug 24, 2022 12:09pm
RE:RE:Confirmation that FDA Meeting is Happening
it was scheduled in Early August & wasn't canceled koo - how else could you take that statement koo?? u had a different take on it??
(116)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Aug 24, 2022 11:51am
RE:Confirmation that FDA Meeting is Happening
Jesus4Prez, is it your understanding from the response you received from Chris at IR is a confirmation that the Type C meeting with FDA has already taken place or is yet to take place? G1945V
(7)
•••
Jesus4Prez
X
View Profile
View Bullboard History
Post by
Jesus4Prez
on Aug 23, 2022 2:16pm
Confirmation that FDA Meeting is Happening
I received the following from Chris at IR when I asked about the FDA Type C Meeting. It sounds like the wheels are still in motion: "Thank you for your inquiry. I can confirm that the FDA
...more
(21)
•••
Storm23
X
View Profile
View Bullboard History
Comment by
Storm23
on Aug 23, 2022 10:39am
RE:RE:where's don
we've had a paid liar as a ceo.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 22, 2022 7:12am
New Press Release - Resverlogix Publishes New Data Highlighting Apabetalone's Benefit in Non-alcoholic Fatty Liver Disease
CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse Cardiovascular Events with the BET Protein Inhibitor Apabetalone in Patients with Recent Acute Coronary...
read article.
(17)
•••
fuzzyjr
X
View Profile
View Bullboard History
Comment by
fuzzyjr
on Aug 16, 2022 4:48pm
RE:where's don
his useless no matter where he hangs imo ... sad that Wong is gone & McCrappy who new FA about science/no schooling etc & istill be in the picture, pathetic...he hung on to Wongs coat tails to
...more
(21)
•••
Storm23
X
View Profile
View Bullboard History
Post by
Storm23
on Aug 13, 2022 9:22am
where's don
last anyones heard he's in Hawii ,i doubt there's anybody in the office working .August meeting with FDA ya right.
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Comment by
Jkj193741
on Jul 26, 2022 10:16pm
RE:RE:RE:RE:RE:problems solved!
MANY THX GV! Jk
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study